Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS In Brief

This article was originally published in The Gray Sheet

Executive Summary

Latest news from the Medicare agency includes updates from the physician fee schedule and clinical laboratory fee schedule, an American Hospital Association lawsuit, and more.

Advertisement

Related Content

MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
ESRD Stakeholders Reiterate Request For More Pay For Home Dialysis Training
CMS Seeks Feedback On Home Dialysis Training Costs In 2014 Draft ESRD Payment Policy
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
Reimbursement In Brief
HHS OIG Expects Almost $4 Billion In Recoveries From First Half Of Fiscal 2013
Industry Groups Push CMS To Pay For Algorithms In Multi-Analyte Tests
CMS Signals Clinical Lab Fee Approach For Molecular Test Codes

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT031719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel